ACTSI Investigator Awarded NIAID Human Immunology Research Award to Help Fight Emerging Infectious Diseases
The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism. The grants were awarded to the Cooperative Centers for Translational Research on Human Immunology and Biodefense (CCHI) and the Immune Mechanisms of Virus Control (IMVC). NIAID also has received approximately $21 million under the American Recovery and Reinvestment Act to supplement these two programs and fund some additional researchers. Rafi Ahmed, PhD, of Emory University, was awarded a portion of approximately $130 million over the next five years under the CCHI program and one year of supplemental Recovery Act funding in addition to the CCHI program funding. The long-term goal of the CCHI and IMVC programs are to identify new vaccines and drug targets. For more information click here.